Friday, Dec 03, 2021
Focus on the big picture

Early results show COVID-19 pill by Chinese company can greatly lower hospitalization risk and death

CGTN, 24 Nov 2021
For more:

A #Chinese drugmaker is reporting positive test results for its COVID-19 pill. Early data from trials in Brazil appear promising, while more information is expected in the coming month. Suzhou-based Kintor Pharma started to develop the drug shortly after the initial outbreak last year. Proxalutamide is the only small-molecule oral drug treatment for #COVID-19 inpatients which has entered phase III multiregional clinical trials.

Subscribe to us on YouTube:
Download our APP on Apple Store (iOS):
Download our APP on Google Play (Android):
Related Articles